BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12469501)

  • 21. Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.
    Ratnoff OD; Emanuelson MM; Ziats NP
    J Clin Invest; 1987 Oct; 80(4):1180-9. PubMed ID: 3498741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
    Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo activation and functions of the protease factor XII.
    Björkqvist J; Nickel KF; Stavrou E; Renné T
    Thromb Haemost; 2014 Nov; 112(5):868-75. PubMed ID: 25187064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process].
    He S; Xiong S; He R; He X; Liu F; Han J; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):118-21. PubMed ID: 11876967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of the activated partial thromboplastin time test using mathematical modeling.
    Kogan AE; Kardakov DV; Khanin MA
    Thromb Res; 2001 Feb; 101(4):299-310. PubMed ID: 11248291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.
    Kleniewski J; Donaldson VH
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):198-202. PubMed ID: 8419923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XII (Hageman Factor) Deficiency: a rare harbinger of life threatening complications.
    Chaudhry LA; El-Sadek WYM; Chaudhry GA; Al-Atawi FE
    Pan Afr Med J; 2019; 33():39. PubMed ID: 31384354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation.
    Peerschke EI; Jesty J; Reid KB; Ghebrehiwet B
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):29-37. PubMed ID: 9607116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HAGEMAN FACTOR DEFICIENCY].
    VERRASTRO T; COSTA MF; JAMRA M
    Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():511-6. PubMed ID: 14119075
    [No Abstract]   [Full Text] [Related]  

  • 32. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (factor XII): report of a case with observation on in vivo and in vitro leukocyte chemotaxis.
    Poon MC; Moore MR; Castleberry RP; Lurie A; Huang ST; Lehmeyer J
    Am J Hematol; 1982 May; 12(3):261-70. PubMed ID: 6919394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombin, enzyme of hemostasis and thrombosis: a model of enzymatic autoregulation].
    Josso F
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():6-9. PubMed ID: 353660
    [No Abstract]   [Full Text] [Related]  

  • 35. Dynamics of pathologic clot formation: a mathematical model.
    Shavlyugin EA; Hanin LG; Khanin MA
    J Theor Biol; 2014 Jan; 340():96-104. PubMed ID: 23973916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Initiation of blood coagulation].
    Saito H
    Rinsho Byori; 1985 Sep; 33(9):960-5. PubMed ID: 3878416
    [No Abstract]   [Full Text] [Related]  

  • 37. Procoagulant activity of surface-immobilized Hageman factor.
    Chatterjee K; Vogler EA; Siedlecki CA
    Biomaterials; 2006 Nov; 27(33):5643-50. PubMed ID: 16905185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mathematical model of the kinetics of platelets and plasma hemostasis system interaction.
    Khanin MA; Leytin VL; Popov AP
    Thromb Res; 1991 Dec; 64(6):659-66. PubMed ID: 1798956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

  • 40. [Factor XII deficiency - Hageman trait. Report of 2 cases].
    Martinić P; Dubravcić M; Vucenik I
    Bilt Hematol Transfuz; 1978; 6(1):29-34. PubMed ID: 755480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.